CHA BIO GROUP

Cell & Gene Tech Investment Forum 2024

2024 Cell & Gene Tech Investment Forum

  • 등록 마감일 2024년 10월 24일(목)
  • 문의 02-6411-7368
Registration

2024

CELL & GENE TECH
INVESTMENT FORUM

2024.10.25 (FRI), 13:00 |
B1F International Conference Hall,
CHA Bio Complex, Pangyo, Korea
Registration
  • 등록 마감일 2024년 10월 24일(목)
  • 문의 02-6411-7368

CGTI FORUM은 세포 유전자치료제분야의 혁신을 이끌어갈 기업과 투자자들을 한자리에 모으는 네트워킹의 장으로,
지난 3월 포럼에는 350명이 현장 참석하여 뜨거운 열기를 보여 주었습니다. 이번 포럼에서도 그 세포 유전자 체료제 산업의
발전 및 상호 협력을 위한 의미 있는 논의를 이어갈 예정입니다.

We are hosting the 2nd CGTI Forum on October 25, 2024.
This event provides IR opportunities for global biotech companies specializing in cell and gene
technology, as well as networking opportunities with investors and other developers. There will be
presentation opportunities for seven companies, so apply to seize this opportunity. At the previous 1st
CGTI Forum, more than 350 participants successfully connected and shared business and scientific
ideas both on-site and on-line. We encourage you to seize this excellent opportunity. Presentations can
be delivered via Zoom or in person.

행사 개요
일시 2024.10.25(금), 13:00
장소 차바이오컴플렉스 국제회의실
주최 차바이오그룹
찾아오시는 길
경기도 성남시 분당구 판교로 335 차바이오컴플렉스
PROGRAM
Time
Topic
Speaker
13:00 - 13:02
Opening
CARM / CHA
13:02 - 13:05
Welcome Remark
Eun-Young Jung Director General /
Bureau of Health Industry(MOHW)
13:05 - 13:12
Off-the-shelf Cell Therapies to Treat
>50% of Cancer Patients Across Hematologic and Solid Tumors
Raphaël G. Ognar President & CEO / NKILT Therapeutics
13:12 - 13:19
Gene therapy platform for nerve-related disorders
Nicolas Tricaud CEO / Nervosave Therapeutics
13:19 - 13:26
rdHSV Gene Therapy for treatment of Chronic Pain
Roelof Rongen CEO / Adolore Biotherapeutics
13:26 - 13:33
Developing novel TCR T-cell therapies
for hematologic malignancies and solid tumors
Keir J. LoIacono CEO / BlueSphere Bio
13:33 - 13:48
Global CGT Landscape and major global trend:
recent advancement and market evolution
Timothy Hunt Chairman / ARM
13:48 - 13:55
Revolutionizing Heart Failure Treatment
with the World’s First ＆Remuscularization＊ Therapy
Kikuo Yasui COO / Heartseed
13:55 - 14:02
AAV Gene Therapy Products for Neuro-degenerative diseases
Taegyun Kim CEO / INNOPEUTICS Co.
14:02 - 14:09
4th Generation CAR-T Therapy for Advanced HCC
Chongsoo Lee BD Managing Director / Eutilex Co., Ltd.
14:09 - 14:24
Introduction of partnering with Astellas
Miki Nakamori Head of Scouting & Transaction / Astellas
14:24 - 14:31
Grab-body for targeted cancer therapy with mRNA LNP
Sangwon Jung CEO / MVRIX Inc.
14:31 - 14:38
GI CELL’s CAR-NK Immune Cell Therapy
Chun-Pyo Hong CEO / GI CELL
14:38 - 14:53
Open innovation at Shonan Health Innovatio Park
for cell and gene therapies
Yasushi Kajii Head of R&D Japan Region / Takeda
14:53 - 15:08
Break
15:08 - 15:23
CHA Global 5 CDMO Sites
Eun Y. Yang CBO & EVP / Cha Bio Group
15:23 - 15:38
Global Open Innovation Center in CGB
Tim Rowe Founder & CEO / Cambridge Innovation Center
15:38 - 15:53
CGT Experience
Paul Kim CEO / Forward Equity Partners
15:53 - 16:00
Design of Novel Oncolytic Immunotherapies
For Intravenous Delivery through the VET Platform
Paul Youm Director of BD / KaliVir Immunotherapeutics
16:00 - 16:07
Mongoose Bio: Transforming cancer treatment with next generation TCR-T therapy
Neil Warma / Cassian Yee President & CEO / Founder / Mongoose Bio
16:07 - 16:14
Gene Therapy: Persistent Functional Efficacy in XLRS Mice
Gary Altman Board of Directors / TeamedOn
16:14 - 16:29
A brief review on recent VC investment trend in biotech industry
- cell & gene therapy case
Seyoung Moon Director / ES Investor
16:29 - 16:36
Novel Gene Therapy by CRISPR-Cas3
Akimitsu Hirai President & CEO / C4U Corporation
16:36 - 16:43
Challenge from blood cancer to solid cancer
Dong Ho Kang General Manager / Abclon
16:43 - 16:50
Stem Cells-derived Mitochondria as Therapeutic Agent
Kyuboem Han CEO / PAEAN Biotechnology. Inc
16:50 - 17:05
Closing
CHA
강연자
  • INVITED SPEAKER

    Timothy Hunt

    Chairman / ARM

    Miki Nakamori

    Head of Scouting & Transaction / Astellas

    Yasushi Kajii

    Head of R&D Japan Region / Takeda

    Tim Rowe

    Founder & CEO /
    Cambridge Innovation Center
  • BIOTECH

    Raphaël G. Ognar

    President & CEO /
    NKILT Therapeutics

    Nicolas Tricaud

    CEO / Nervosave Therapeutics

    Roelof Rongen

    CEO / Adolore Biotherapeutics

    Keir J. LoIacono

    CEO / BlueSphere Bio

    Taegyun Kim

    CEO / INNOPEUTICS Co.

    Chongsoo Lee

    BD Managing Director /
    Eutilex Co., Ltd.

    Chun-Pyo Hong

    CEO / GI CELL

    Akimitsu Hirai

    President & CEO / C4U Corporation

    Kikuo Yasui

    COO / Heartseed

    Paul Youm

    Director of BD /
    KaliVir Immunotherapeutics

    Neil Warma

    President & CEO / Mongoose Bio

    Cassian Yee

    Founder / Mongoose Bio

    Gary Altman

    Board of Directors / TeamedOn

    Dong Ho Kang

    General Manager / Abclon

    Kyuboem Han

    CEO / PAEAN Biotechnology. Inc

    Sangwon Jung

    CTO / MVRIX Inc.
  • INVESTOR

    Paul Kim

    CEO / Forward Equity Partners

    Seyoung Moon

    Director / ES Investor
  • CHA BIO GROUP

    Eun Y. Yang

    CBO & EVP / Cha Bio Group